Company research / SILO
Silo Pharma, Inc. (SILO)
- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Silo Pharma, Inc. reported revenue of $72.1K. Revenue grew 0.0% from the prior annual period.
Key ratios (year ended 2025-12-31)
38.6%
Gross margin
-5937.0%
Operating margin
-5863.5%
Net margin
-67.0%
Return on year-end equity
0.0%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.